Statistics for OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH)

Total visits

views
OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH) 170

Total visits per month

views
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0

File Visits

views
OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional T.pdf 153
java.util.UUID:58955041-86d2-41c9-9477-5f21d1228704 53
java.util.UUID:42bb50bc-05b7-47b3-8049-e14f3cc97a54 18
java.util.UUID:8048011a-bd62-4841-b8cf-5413ac11fb39 10

Top country views

views
United States 136
Germany 5
Ukraine 5
United Kingdom 3
Canada 2
China 2
Malaysia 1

Top city views

views
Wilmington 47
Fairfield 22
Cambridge 12
Ann Arbor 10
Houston 10
Jacksonville 5
Kiev 5
Kiez 3
Beijing 2
Seattle 2
Toronto 2
Baltimore 1
Bloomsbury 1
Brooklyn 1
Elmshorn 1
Gunzenhausen 1
Irvine 1
Mount Laurel 1
San Francisco 1
Scottsdale 1
Seremban 1